Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:
“NOK 2025 day 2. GI session and advanced HCC. CheckMate 9DW: NIVO+IPI showed significant OS and ORR benefit vs LEN/SOR in untreated unresectable HCC. More CRs, durable responses, improved PFS at 18/24 mo, manageable toxicity. Supports NIVO+IPI as a 1L option.”
More posts featuring Kristina Jankovic.
